CATHY KLEMA - 02 Feb 2024 Form 4 Insider Report for OptimizeRx Corp (OPRX)

Role: Director
Signature: /s/ Marion Odence-Ford, by Power of Attorney
Issuer symbol: OPRX
Transactions as of: 02 Feb 2024
Net transactions value: $0
Form type: 4
Filing time: 06 Feb 2024, 19:53:05 UTC
Previous filing: 02 Feb 2024
Next filing: 11 Jun 2024
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OPRX	Restricted Stock Units	Award	$0	+5,109		$0.000000	5,109	02 Feb 2024	Common Stock	5,109		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of OptimizeRx common stock.
F2	The restricted stock units will vest in full on the first anniversary of the date of grant.

Remarks:

The filing of this Statement shall not be construed as an admission (a) that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this Statement, or (b) that this Statement is legally required to be filed by such person.